Biography

Dr. Rebecca Lin is a pulmonologist who has been involved in programmatic management of drug-resistant tuberculosis in Taiwan since 2007. Besides extensive programmatic experience, she has also participated as a consultant in international training courses of clinical management of drug-resistant tuberculosis for the Union as well as providing technical assistance in Southeast Asia.

Expertise

TB Diagnostics
Public Health

Key Impacts

Adverse events in the treatment of rifampicin-resistant TB: Findings of comprehensive active drug-safety monitoring and management

SAEs in the treatment of MDR/RR-TB were more frequent than previously reported and needed to be closely monitored and timely managed by systemic and comprehensive aDSM.

Source: Conference 2024